Understanding Metabolic Regulation and Its Influence on Cell Physiology

Department of Bioengineering, University of California, San Diego, La Jolla, CA 92093, USA. Electronic address: .
Molecular cell (Impact Factor: 14.02). 02/2013; 49(3):388-98. DOI: 10.1016/j.molcel.2013.01.018
Source: PubMed


Metabolism impacts all cellular functions and plays a fundamental role in biology. In the last century, our knowledge of metabolic pathway architecture and the genomic landscape of disease has increased exponentially. Combined with these insights, advances in analytical methods for quantifying metabolites and systems approaches to analyze these data now provide powerful tools to study metabolic regulation. Here we review the diverse mechanisms cells use to adapt metabolism to specific physiological states and discuss how metabolic flux analyses can be applied to identify important regulatory nodes to understand normal and pathological cell physiology.

Full-text preview

Available from:
  • Source
    • "additional oncogenic mutations, tumor microenvironment). Lactate dehydrogenase A (LDHA) is commonly upregulated in cancer cells downstream of HIF1α and Myc signaling (Kim et al., 2007; Dang et al., 2008; Cairns et al., 2011); this enzyme helps maintain glycolysis via NAD+ regeneration (Metallo & Vander Heiden, 2013). One recent study observed that IDH mutant gliomas and tumor-derived brain tumor stem cells silence LDHA expression through promoter hypermethylation (Chesnelong et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Specific point mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) occur in a variety of cancers, including acute myeloid leukemia (AML), low-grade gliomas, and chondrosarcomas. These mutations inactivate wild-type enzymatic activity and convey neomorphic function to produce D-2-hydroxyglutarate (D-2HG), which accumulates at millimolar levels within tumors. D-2HG can impact α-ketoglutarate-dependent dioxygenase activity and subsequently affect various cellular functions in these cancers. Inhibitors of the neomorphic activity of mutant IDH1 and IDH2 are currently in Phase I/II clinical trials for both solid and blood tumors. As IDH1 and IDH2 represent key enzymes within the tricarboxylic acid (TCA) cycle, mutations have significant impact on intermediary metabolism. The loss of some wild-type metabolic activity is an important, potentially deleterious and therapeutically exploitable consequence of oncogenic IDH mutations and requires continued investigation in the future. Here we review how IDH1 and IDH2 mutations influence cellular metabolism, epigenetics, and other biochemical functions, discussing these changes in the context of current efforts to therapeutically target cancers bearing these mutations. Copyright © 2015. Published by Elsevier Inc.
    Pharmacology [?] Therapeutics 05/2015; 152. DOI:10.1016/j.pharmthera.2015.05.003 · 9.72 Impact Factor
  • Source
    • "Please cite this article in press as: Vacanti et al., Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier, Molecular Cell (2014), http:// (Figure 2F) (Le et al., 2012; Metallo and Vander Heiden, 2013). In the glutaminolysis pathway, glutamine is oxidized in the mitochondria and converted to pyruvate via malic enzymes (MEs). "

    Molecular cell 11/2014; · 14.02 Impact Factor
  • Source
    • "carbon metabolism (Figure S3B). Altered utilization of central carbon metabolites and switches in bioenergetic programs by cancer cells are becoming recognized as critical components of the oncogenic potential of many cancers (Hitosugi et al., 2012; Locasale et al., 2011; Metallo and Vander Heiden, 2013; Mullen et al., 2012; Oliva et al., 2010; Possemato et al., 2011; Son et al., 2013); thus, AK4's involvement in these processes may represent its association with cancer patient survival. Similar to the effects that we observe upon AK4 knockdown, Snijder et al. recently reported that siRNA-mediated knockdown of AK5 in HeLa cells also increased proliferation (Snijder et al., 2012), and other groups have implicated nucleotide biogenesis in oncogenic potential (Stenesen et al., 2013; Wawrzyniak et al., 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Altered cellular bioenergetics and mitochondrial function are major features of several diseases, including cancer, diabetes, and neurodegenerative disorders. Given this important link to human health, we sought to define proteins within mitochondria that are critical for maintaining homeostatic ATP levels. We screened an RNAi library targeting >1,000 nuclear-encoded genes whose protein products localize to the mitochondria in multiple metabolic conditions in order to examine their effects on cellular ATP levels. We identified a mechanism by which electron transport chain (ETC) perturbation under glycolytic conditions increased ATP production through enhanced glycolytic flux, thereby highlighting the cellular potential for metabolic plasticity. Additionally, we identified a mitochondrial adenylate kinase (AK4) that regulates cellular ATP levels and AMPK signaling and whose expression significantly correlates with glioma patient survival. This study maps the bioenergetic landscape of >1,000 mitochondrial proteins in the context of varied metabolic substrates and begins to link key metabolic genes with clinical outcome.
    Cell Reports 04/2014; 7(3). DOI:10.1016/j.celrep.2014.03.065 · 8.36 Impact Factor
Show more